BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9210184)

  • 1. Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers.
    Byron PR; Peart J; Staniforth JN
    Pharm Res; 1997 Jun; 14(6):698-705. PubMed ID: 9210184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of relative humidity on the electrostatic charge properties of dry powder inhaler aerosols.
    Kwok PC; Chan HK
    Pharm Res; 2008 Feb; 25(2):277-88. PubMed ID: 17619997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Relative Humidity on Bipolar Electrostatic Charge Profiles of dry Powder Aerosols.
    Yu J; Wong J; Ukkonen A; Kannosto J; Chan HK
    Pharm Res; 2017 Aug; 34(8):1707-1715. PubMed ID: 28540500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
    Telko MJ; Kujanpää J; Hickey AJ
    Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
    Martin GP; Marriott C; Zeng XM
    Pharm Res; 2007 Feb; 24(2):361-9. PubMed ID: 17177114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI).
    Hoe S; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
    Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM; Pandhal KH; Martin GP
    Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of particle morphology on the triboelectrification in dry powder inhalers.
    Murtomaa M; Mellin V; Harjunen P; Lankinen T; Laine E; Lehto VP
    Int J Pharm; 2004 Sep; 282(1-2):107-14. PubMed ID: 15336386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.
    Smith KJ; Chan HK; Brown KF
    J Aerosol Med; 1998; 11(4):231-45. PubMed ID: 10346666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN; Bierend H; Robins E; Steckel H; Flament MP
    Int J Pharm; 2012 Jan; 422(1-2):75-82. PubMed ID: 22036653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrostatic charge characteristics of jet nebulized aerosols.
    Kwok PC; Trietsch SJ; Kumon M; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):149-59. PubMed ID: 20500092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR).
    Wong J; Lin YW; Kwok PC; Niemelä V; Crapper J; Chan HK
    Mol Pharm; 2015 Sep; 12(9):3433-40. PubMed ID: 26222019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerodynamic and electrostatic properties of model dry powder aerosols: a comprehensive study of formulation factors.
    Telko MJ; Hickey AJ
    AAPS PharmSciTech; 2014 Dec; 15(6):1378-97. PubMed ID: 24938617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics.
    Begat P; Morton DA; Staniforth JN; Price R
    Pharm Res; 2004 Oct; 21(10):1826-33. PubMed ID: 15553229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®.
    Hoe S; Young PM; Traini D
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1365-75. PubMed ID: 21554161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle size selection device for use with the Turbohaler.
    Everard ML; Devadason SG; Le Souef PN
    Thorax; 1996 May; 51(5):537-9. PubMed ID: 8711685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.